Literature DB >> 29799771

Is the Dexamethasone-Sparing Strategy Ready For Cisplatin? Too Early For an Answer.

Luigi Celio1, Erminio Bonizzoni1, Matti Aapro1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29799771     DOI： 10.1200/JCO.2018.78.8109

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: a meta-analysis of randomised evidence.

Authors:  Luigi Celio; Erminio Bonizzoni; Emma Zattarin; Paolo Codega; Filippo de Braud; Matti Aapro
Journal:  BMC Cancer       Date:  2019-12-30       Impact factor: 4.430

2.  Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study.

Authors:  Luigi Celio; Diego Cortinovis; Alessio Aligi Cogoni; Luigi Cavanna; Olga Martelli; Simona Carnio; Elena Collovà; Federica Bertolini; Fausto Petrelli; Alessandra Cassano; Rita Chiari; Francesca Zanelli; Salvatore Pisconti; Isabella Vittimberga; Antonietta Letizia; Andrea Misino; Angela Gernone; Erminio Bonizzoni; Sara Pilotto; Sabino De Placido; Emilio Bria
Journal:  Oncologist       Date:  2021-06-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.